Who we are
The Catalytic Impact Foundation (CIF) is a 501c3 organization that aggregates philanthropic capital to make impact investments in early-stage life science and healthcare companies addressing unmet medical needs. Using an evergreen fund model, which CIF has coined “regenerative philanthropy”, returns from investments go back into the fund to be recycled for more impact. Billions of dollars are spent annually funding scientific research, but just a small fraction of that research ever leaves the lab, often due to lack of funding once the technology reaches the commercial stage of development. CIF works to address the funding gap for early-stage companies throughout North America, Europe and Israel, to help them through the “Valley of Death” and along the path to commercialization. We bring the discipline of venture capital investing to making impactful venture philanthropy investments.
Current UAM
<25M
Sectors
Biotech, Healthcare, Other
Stages
Pre-Seed, Seed, Series A
Regions
Europe, Middle East and North Africa (MENA), North America, South Asia and Central Asia
Countries
India, Ireland, Israel, UK, US
Founding / General Partners
Rachel Butler, Richard Lipkin, Rob Wolk
Why are we taking the Beyond The Billion Pledge?
The Catalytic Impact Foundation is taking the pledge because we believe that diversity drives innovation, and innovation suffers when more than 50% of the population struggle to access capital. We actively look for companies led by women (and other diverse leaders) with transformative technologies addressing unmet healthcare needs.